Table 1. Baseline and Demographic Characteristics of Study Patients.
| Elderly (n = 38) | Non-Elderly (n = 143) | P value | |
| Age, y, mean ± SD | 68.8 ± 4.4 | 49.5 ± 11.2 | 0.00 |
| Female, No. (%) | 14 (36.8) | 67 (46.9) | 0.36 |
| Body mass index, mean ± SD | 22.7 ± 2.9 | 23.7 ± 3.4 | 0.11 |
| Cirrhosis, NO. (%) | 9 (23.7) | 24 (16.8) | 0.35 |
| Platelet count (× 103/mm3), mean ± SD | 153.8 ± 53.9 | 167.1 ± 57.7 | 0.19 |
| AST a, IU/L, mean ± SD | 66.1 ± 37.5 | 73.0 ± 53.4 | 0.36 |
| ALTa, IU/L, mean ± SD | 71.9 ± 58.1 | 80.1 ± 68.9 | 0.46 |
| Total bilirubin, mg/dL, mean ± SD | 0.8 ± 0.4 | 0.7 ± 0.3 | 0.04 |
| Albumin, g/dL, mean ± SD | 4.1 ± 0.4 | 4.2 ± 0.4 | 0.03 |
| APRI a score, mean ± SD | 1.2 ± 0.8 | 1.3 ± 1.2 | 0.51 |
| Serum HCV a RNA level, Log10 IU/mL, mean ± SD | 5.6 ± 0.8 | 5.6 ± 0.9 | 0.91 |
| HCV genotype, No. (%) | 1.00 | ||
| Type 1 | 13 (34.2) | 47 (32.9) | |
| Type 2 or 3 | 25 (65.8) | 96 (67.1) |
a Abbreviations: ALT, Alanine Aminotransferase; APRI, platelet ratio index; AST, Aspartate Aminotransferase; HCV, hepatitis C virus